These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 20926880

  • 1. Hepatotoxicity of agents used in the management of inflammatory bowel disease.
    Khokhar OS, Lewis JH.
    Dig Dis; 2010; 28(3):508-18. PubMed ID: 20926880
    [Abstract] [Full Text] [Related]

  • 2. Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.
    Rojas-Feria M, Castro M, Suárez E, Ampuero J, Romero-Gómez M.
    World J Gastroenterol; 2013 Nov 14; 19(42):7327-40. PubMed ID: 24259964
    [Abstract] [Full Text] [Related]

  • 3. Hepatic Complications of Inflammatory Bowel Disease.
    Mahfouz M, Martin P, Carrion AF.
    Clin Liver Dis; 2019 May 14; 23(2):191-208. PubMed ID: 30947871
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Risk of developing tuberculosis under anti-TNF treatment despite latent infection screening.
    Jauregui-Amezaga A, Turon F, Ordás I, Gallego M, Feu F, Ricart E, Panés J.
    J Crohns Colitis; 2013 Apr 14; 7(3):208-12. PubMed ID: 22677117
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dosing 6-thioguanine in inflammatory bowel disease: expert-based guidelines for daily practice.
    Seinen ML, van Asseldonk DP, Mulder CJ, de Boer NK.
    J Gastrointestin Liver Dis; 2010 Sep 14; 19(3):291-4. PubMed ID: 20922194
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks.
    Massironi S, Pirola L, Mulinacci G, Ciaccio A, Viganò C, Palermo A, Zilli A, Invernizzi P, Danese S.
    Inflamm Bowel Dis; 2023 Sep 01; 29(9):1477-1487. PubMed ID: 36040402
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The impact of immunosuppressive therapy on QuantiFERON and tuberculin skin test for screening of latent tuberculosis in patients with inflammatory bowel disease scheduled for anti-TNF therapy.
    Mantzaris GJ, Tsironikos D, Tzanetakou X, Grispou E, Karatzas P, Kalogeropoulos I, Papamichael K.
    Scand J Gastroenterol; 2015 Sep 01; 50(12):1451-5. PubMed ID: 26139305
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.